119 results on '"Pöttgen, Christoph"'
Search Results
2. Strahlentherapie in der geriatrischen Urologie
Catalog
Books, media, physical & digital resources
3. Anti-PD-(L)1 plus BRAF/MEK inhibitors (triplet therapy) after failure of immune checkpoint inhibition and targeted therapy in patients with advanced melanoma
4. T-VEC in the palliative treatment of Mucosal Melanoma
5. T-VEC Injektion im palliativen Setting von Schleimhautmelanomen
6. Long-Term Survival in Patients with Oligometastatic Non-Small Cell Lung Cancer by a Multimodality Treatment—Comparison with Stage III Disease
7. Experimental Examination of Conventional, Semi-Automatic, and Automatic Volumetry Tools for Segmentation of Pulmonary Nodules in a Phantom Study
8. Survivorship Program Including Long-Term Toxicities and Quality-of-Life Development Over Ten Years within a Randomized Phase-III Trial in Operable Stage III Non-Small-Cell Lung Cancer (ESPATUE)
9. Impact of Modern Low Dose Involved Site Radiation Therapy on Normal Tissue Toxicity in Cervicothoracic Non-Hodgkin Lymphomas: A Biophysical Study
10. Adaptation Time as a Determinant of the Dosimetric Effectiveness of Online Adaptive Radiotherapy for Bladder Cancer
11. CTNI-65. INVESTIGATING SAFETY AND EFFICACY OF TTFIELDS PRIOR AND CONCOMITANT TO RADIOTHERAPY IN NEWLY DIAGNOSED GLIOBLASTOMA - FIRST RESULTS OF THE PRICOTTF PHASE I/II TRIAL
12. Fractionation versus Adaptation for Compensation of Target Volume Changes during Online Adaptive Radiotherapy for Bladder Cancer: Answers from a Prospective Registry
13. Giant middle mediastinal lesions: when tumor size correlates with mesenchymal origin—a retrospective single-center analysis
14. Radiation Therapy in Non-small-Cell Lung Cancer
15. Safety and efficacy of tumor treating fields (TTFields) prior and concomitant to radiotherapy in patients with newly diagnosed glioblastoma: Results from PriCoTTF.
16. Location of Recurrences after Trimodality Treatment for Glioblastoma with Respect to the Delivered Radiation Dose Distribution and Its Influence on Prognosis
17. Comparison of Online-Onboard Adaptive Intensity-Modulated Radiation Therapy or Volumetric-Modulated Arc Radiotherapy With Image-Guided Radiotherapy for Patients With Gynecologic Tumors in Dependence on Fractionation and the Planning Target Volume Margin
18. Lokalisierte Weichgewebesarkome
19. Machine-learning-based prediction of the effectiveness of the delivered dose by exhale-gated radiotherapy for locally advanced lung cancer: The additional value of geometric over dosimetric parameters alone
20. CTNI-29. INVESTIGATING SAFETY AND EFFICACY OF TTFIELDS PRIOR AND CONCOMITANT TO RADIOTHERAPY IN NEWLY DIAGNOSED GLIOBLASTOMA - FIRST RESULTS OF THE PRICOTTF PHASE I/II TRIAL
21. Prediction of malignant lymph nodes in NSCLC by machine-learning classifiers using EBUS-TBNA and PET/CT
22. Feasibility, Method and Early Outcome of Image-Guided Volumetric Modulated Arc Radiosurgery Followed by Resection for AJCC Stage IIA–IIIB High-Risk Large Intraocular Melanoma
23. [68Ga]FAPI-PET/CT for radiation therapy planning in biliary tract, pancreatic ductal adeno-, and adenoidcystic carcinomas
24. Effectiveness of durvalumab consolidation in stage III non-small-cell lung cancer: focus on treatment selection and prognostic factors
25. Long-term survival of patients with central or > 7 cm T4 N0/1 M0 non-small-cell lung cancer treated with definitive concurrent radiochemotherapy in comparison to trimodality treatment
26. Time interval between the diagnosis of breast cancer and brain metastases impacts prognosis after metastasis surgery
27. Prognostic Factors for Leiomyosarcoma with Isolated Metastases to the Lungs: Impact of Metastasectomy
28. Strahlentherapie in der geriatrische Urologie
29. Prediction of Short and Long Survival after Surgery for Breast Cancer Brain Metastases
30. Therapie des metastasierten Mammakarzinoms
31. Electrolyte and renal disorders in patients with newly diagnosed glioblastoma
32. Interactions Between Dose and Volume in Chemoradiotherapy of Esophageal Cancer
33. Role of Postoperative Radiotherapy in the Management for Resected NSCLC – Decision Criteria in Clinical Routine Pre- and Post-LungART
34. Radiographic markers of breast cancer brain metastases: relation to clinical characteristics and postoperative outcome
35. Patterns of nodal spread in stage III NSCLC: importance of EBUS-TBNA and 18F-FDG PET/CT for radiotherapy target volume definition
36. Localized Angiosarcoma, Not One Disease: A Retrospective Single-Center Study on Prognosis Depending on the Primary Site and Etiology
37. Significantly favourable outcome for patients with non-small-cell lung cancer stage IIIA/IIIB and single-station persistent N2 (skip or additionally N1) disease after multimodality treatment
38. HER2 Receptor Conversion Is a strong Survival Predictor in Patients with Breast Cancer Brain Metastases
39. Prognostic Value of Postinduction Chemotherapy Volumetric PET/CT Parameters for Stage IIIA or IIIB Non–Small Cell Lung Cancer Patients Receiving Definitive Chemoradiotherapy
40. Number of metastases and their response to chemotherapy impact survival of patients with isolated lung metastases from bone-derived sarcoma
41. Surgical Treatment for Primary Chest Wall Sarcoma: A Single-Institution Study
42. Altered Fractionation Schemes in Radiotherapy
43. Impact of EBUS-TBNA in addition to [18F]FDG-PET/CT imaging on target volume definition for radiochemotherapy in stage III NSCLC
44. Dosimetric impact of the positioning variation of tumor treating field electrodes in the PriCoTTF‐phase I/II trial
45. Role of radiotherapy in the management of brain metastases of NSCLC – Decision criteria in clinical routine
46. Spatial and dosimetric evaluation of residual distortions of prostate and seminal vesicle bed after image‐guided definitive and postoperative radiotherapy of prostate cancer with endorectal balloon
47. 18F-FDG PET/CT for Target Volume Contouring in Lung Cancer Radiotherapy (perspective on “Comparison of Different Methods for Delineation of 18F-FDG PET–Positive Tissue for Target Volume Definition in Radiotherapy of Patients with Non–Small Cell Lung Cancer” J Nucl Med. 2005;46:1342–1348)
48. MBCL-11. TIME TO RADIOTHERAPY IMPACTS SURVIVAL IN PEDIATRIC AND ADOLESCENT NON-METASTATIC MEDULLOBLASTOMA TREATED BY UPFRONT RADIOTHERAPY – A REPORT FROM THE HIT 2000 TRIAL
49. ESTRO ACROP guidelines for target volume definition in the thoracic radiation treatment of small cell lung cancer
50. Evaluation of Prognostic Factors and Role of Participation in a Randomized Trial or a Prospective Registry in Pediatric and Adolescent Nonmetastatic Medulloblastoma – A Report From the HIT 2000 Trial
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.